Eterna Therapeutics Inc
NASDAQ:ERNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
A
|
Air Canada
F:ADH2
|
CA |
|
D
|
Dolby Laboratories Inc
XMUN:FUO
|
US |
|
Flitways Technology Inc
OTC:FTWS
|
US |
|
Sulzer AG
SIX:SUN
|
CH |
|
ITM Power PLC
LSE:ITM
|
UK |
|
M
|
McCormick & Company Inc
XMUN:MCX
|
US |
|
Jet2 PLC
LSE:JET2
|
UK |
|
W
|
Woodside Petroleum Ltd
F:WOPA
|
AU |
|
Hello Group Inc
F:1MO
|
CN |
|
V
|
Vicor Corp
F:VCV
|
US |
|
A
|
Aegean Airlines SA
F:32A
|
GR |
|
F
|
Fresenius SE & Co KGaA
F:FREA
|
DE |
|
Cdon AB
OTC:CDOAF
|
SE |
|
Creotech Instruments SA
F:5OB
|
PL |
|
E
|
Ems Chemie Holding AG
XMUN:EMC1
|
CH |
|
T
|
Taylor Morrison Home Corp
F:THM
|
US |
Wall St Price Targets
ERNA Price Targets Summary
Eterna Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ERNA is 30.6 USD with a low forecast of 30.3 USD and a high forecast of 31.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ERNA's stock price target?
Price Target
30.6
USD
According to Wall Street analysts, the average 1-year price target for
ERNA is 30.6 USD with a low forecast of 30.3 USD and a high forecast of 31.5 USD.